Evidence map›Paper›PMID 42440948›Full record

ArticleJCEM case reports2026

Metachronous contralateral pheochromocytoma detected 62 years after initial surgery.

Yoshie Kawabe, Kuniaki Ozaki, Aki Niinomi, Miho Katsumata, Junko Nakaue, Yutaka Takahashi

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yoshie KawabeDepartment of Diabetes and Endocrinology, Nara Medical University, Kashihara, Nara 634-8521, Japan.ORCID https://orcid.org/0009-0009-4487-8193
Kuniaki OzakiDepartment of Diabetes and Endocrinology, Nara Medical University, Kashihara, Nara 634-8521, Japan.
Aki NiinomiDepartment of Diabetes and Endocrinology, Nara Medical University, Kashihara, Nara 634-8521, Japan.
Miho KatsumataDepartment of Diabetes and Endocrinology, Nara Medical University, Kashihara, Nara 634-8521, Japan.
Junko NakaueDepartment of Diabetes and Endocrinology, Nara Medical University, Kashihara, Nara 634-8521, Japan.
Yutaka TakahashiDepartment of Diabetes and Endocrinology, Nara Medical University, Kashihara, Nara 634-8521, Japan.ORCID https://orcid.org/0000-0002-1337-9246

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pheochromocytoma and paraganglioma (PPGL) are neuroendocrine tumors with malignant potential. Although surgery is often curative, local recurrence, metastatic disease, or new tumors can occur even decades later; therefore, long-term follow-up for at least 10 years is generally recommended. We present a case of metachronous contralateral pheochromocytoma (PCC) diagnosed 62 years after the initial surgery-the longest postoperative interval reported through our literature search. We identified an old Japanese case report of the same patient that contained valuable clinical data and treatment details, providing a unique opportunity for longitudinal comparison of the initial and later clinical courses across 6 decades. Interestingly, the second tumor showed a shift from a mixed epinephrine-norepinephrine secretory profile to a predominantly norepinephrine profile, suggesting a potential change in the tumor characteristics over time. Although the patient declined surgery and genetic testing, a genetic etiology of PCC was suspected. This case highlights the importance of lifelong follow-up for all patients with PPGL, regardless of apparent cure.

Indexed as

bilateral pheochromocytomalongest intervalmetachronousrecurrence

Identifiers

PMID42440948
PMCPMC13334095

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.